Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Seizures ll: Types

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...

Seizures: Classification

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

Seizures l: Introduction

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional study.

Orphanet journal of rare diseases·2026

Same author

Beyond the interferon score: neurofilament light chain and glial fibrillary acidic protein capture immune-mediated neuroinjury and response to JAK inhibition in Aicardi-Goutières syndrome.

Frontiers in immunology·2026

Same author

Generation of an isogenic human induced pluripotent stem cell line harbouring a CLDN11 mutation associated with hypomyelinating leukodystrophy.

Stem cell research·2026

Same author

Influence of a 12 week at-home resistance exercise program on <sup>13</sup>C-glucose metabolism in patients with metabolic myopathies.

Molecular genetics and metabolism·2026

Same author

The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency.

Brain : a journal of neurology·2025

Same author

Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study.

Journal of neuromuscular diseases·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Seizure Activity Induced by Electroshock in Drosophila Larvae

Seizure Activity Induced by Electroshock in Drosophila Larvae

Published on: June 6, 2025

Vitamin B6 dependent seizures.

Barbara Plecko¹, Sylvia Stöckler

¹Division of Biochemical Diseases and Cystic Fibrosis, Children's and Women's Health Center, University of British Columbia, Vancouver, BC, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques

|September 19, 2009

Summary

Four genetic epilepsies linked to vitamin B6 metabolism cause severe neonatal seizures. Early diagnosis and targeted treatment with pyridoxal-5'-phosphate (PLP) are crucial to prevent neurological damage.

More Related Videos

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Related Experiment Videos

Last Updated: Jun 20, 2026

Seizure Activity Induced by Electroshock in Drosophila Larvae

Seizure Activity Induced by Electroshock in Drosophila Larvae

Published on: June 6, 2025

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Area of Science:

Biochemistry
Neuroscience
Genetics

Background:

Vitamin B6 is essential for amino acid and neurotransmitter metabolism, with its active form being pyridoxal-5'-phosphate (PLP).
Physiological availability relies on diet, absorption, and liver conversion.
Genetic disorders affecting vitamin B6 metabolism can lead to severe neurological conditions.

Purpose of the Study:

To review genetic epilepsies associated with vitamin B6 metabolism.
To highlight diagnostic approaches and treatment strategies for these rare disorders.
To emphasize the importance of early diagnosis in preventing irreversible neurological damage.

Main Methods:

Review of literature on genetic epilepsies related to vitamin B6.
Analysis of diagnostic biomarkers and molecular confirmation.
Discussion of treatment outcomes with pyridoxine and PLP.

Main Results:

Identified four genetic epilepsies: PNPO deficiency, infantile hypophosphatasia, pyridoxine-dependent epilepsy, and hyperprolinemia type II.
Two disorders involve reduced PLP synthesis (PNPO, hypophosphatasia), and two involve increased PLP utilization (pyridoxine-dependent epilepsy, hyperprolinemia II).
These conditions often present with therapy-resistant neonatal seizures, with variable EEG findings.

Conclusions:

Early consideration of these vitamin B6-dependent epilepsies is vital for neonatal therapy-resistant seizures.
While PLP benefits all four, PNPO deficiency requires direct PLP substitution due to pyridoxine resistance.
Timely diagnosis and intervention can prevent severe neurological sequelae.